So They Say

The Genome on A Patent Platter? Congress, of course, does not own the human genome; nor is there any way under American law for Congress to stake out hegemony over our double helix and transfer a portion of this hegemony to others. The key lies in appreciating the First Amendment. My notion is that the biological universe and our perceptions of that universe comprise an idea marketplace. Debate over competing theories of this biological reality lies at the core of free expression and presuppos

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Congress, of course, does not own the human genome; nor is there any way under American law for Congress to stake out hegemony over our double helix and transfer a portion of this hegemony to others. The key lies in appreciating the First Amendment. My notion is that the biological universe and our perceptions of that universe comprise an idea marketplace. Debate over competing theories of this biological reality lies at the core of free expression and presupposes universal access to the reality under investigation. As Congress lacks the power to punish dissemination of these theories, so Congress lacks power to carve out segments of that idea marketplace and put them in the hands of any person or group to be allocated as they see fit.

... Shakespeare would be entitled to clothe Hamlet’s speeches in copyright dress, but Congress could not hand Einstein E = mc^2 on a patent ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies